Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven
Florian Henning Geyer1,2,3,4, Alina Ritter1,2,3,4, Seneca Kinn-Gurzo5
1Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Cancer Communications (London, England)
|March 15, 2025
Abstract
No abstract available in PubMed .


